EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer
S. D. Soysal, S. Muenst, T. Barbie, T. Fleming, F. Gao, G. Spizzo, D. Oertli, C. T. Viehl, E. C. Obermann, W. E. Gillanders
Dive into the research topics of 'EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer'. Together they form a unique fingerprint.